Rwanda Withdraws Tablets Manufactured In Kenya From Market, Orders Sellers To Stop Distributing It

• Rwanda recalled Fluconazole 200mg tablets manufactured in Kikuyu, raising questions about the production standards in Kenya
• Importers and suppliers of the tablets were asked to submit reports to the country's Food and Drug Authority within a 10-day period starting from the recall date
• The government led by President Paul Kagame aims to investigate the negative impacts that the drug has had on the Rwandan population

TUKO.co.ke journalist Japhet Ruto brings over eight years of experience in financial, business, and technology reporting, offering deep insights into Kenyan and global economic trends.

Rwanda has issued a recall for Fluconazole 200mg tablets manufactured in Kenya, directing wholesalers and importers to stop distributing them.

The East African country's Food and Drug Authority's (FDA) recall came amid concerns over the quality and safety of the tablets, raising questions about the manufacturing standards in Kenya.

Universal Corporation manufactures the tablets in Kikuyu. The suspended tablets for sale were under the following batches: 5810315, 5810316, 5811390 and 5810022. The pink tablets allegedly displayed white discolouration.

"Rwanda FDA instructs all importers, central medical stores, wholesalers, RMS branches, retailers, and public and private health facilities to stop the distribution of the above-mentioned batches of fluconazole 200mg tablets and return them to their suppliers for proper management," Emile Bienvenu, the director general of Rwanda FDA stated.

Additionally, importers and suppliers of the tablets were asked to submit reports to the FDA within 10 days starting from the recall date.

The government, led by President Paul Kagame, aims to investigate the negative impacts of the drug on the Rwandan population.

Why the Ministry of Health recalled paracetamol

Back home, the Pharmacy and Poisons Board (PPB) said it had received numerous complaints regarding the Tamedol oral solution manufactured by Biopharma Ltd Kenya.

Their investigations showed that the popular painkillers do not meet the required market authorisation.

Consequently, PPB immediately immediately recalled the drug from the market to protect Kenyans.

"Stop all further distribution, sale, issuing or use of Tamedol Oral solution. Members of the public are urged to return the product to their nearest healthcare facility, while healthcare facilities are instructed to return the product to their respective suppliers," PPB stated.

Davji Atellah: Why doctors are unhappy

In other news, doctors in Kenya once again raised a concern over the state of the healthcare system.

The Kenya Medical Practitioners Pharmacists Dentists Union (KMPDU) said it was a collective call for urgent action to address the critical issues plaguing the healthcare system.

Led by the union's secretary general, Davji Bhimji Atellah, the doctors said the issues had a direct impact on the quality of care our Kenyans receive in private and public hospitals.